Safety/ITT population | |||||||
---|---|---|---|---|---|---|---|
ABvac40 (n = 16) | Placebo (n = 8) | Total (N = 24) | |||||
AEs (n) | No. of patients (%) | AEs (n) | No. of patients (%) | AEs (n) | No. of patients (%) | p Value | |
Total AEs | 42 | 11 (69%) | 29 | 7 (88%) | 71 | 18 (75%) | 0.6214 |
Neurological | 9 | 5 (31%) | 6 | 5 (63%) | 15 | 10 (42%) | 0.2038 |
Psychiatric | 2 | 2 (13%) | 1 | 1 (13%) | 3 | 3 (13%) | 1.0000 |
Cardiovascular | 1 | 1 (6%) | 1 | 1 (13%) | 2 | 2 (8%) | 1.0000 |